Home/Tasman Therapeutics/Professor Paul Glue

PP

Professor Paul Glue

Clinical Advisory Board Chair & Chief Medical Officer

Tasman Therapeutics

Therapeutic Areas

Psychiatry Treatment-Resistant Depression Mood Disorders

Tasman Therapeutics Pipeline

Drug	Indication	Phase
R-107	Treatment-Resistant Depression (TRD)	Phase 3

Leadership Team at Tasman Therapeutics

Chief Executive Officer

Dr. Peter Surman

Chief Scientific Officer

Chief Legal and Commercial Officer

Chief Financial Officer

View full Tasman Therapeutics profile